Chemical Structure (Tazarotene 01)
Tazarotene Aerosol, Foam
Product Images NDC 68308-685
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 68308-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Tazarotene 02)
Figure B (Tazarotene 03)
Figure C (Tazarotene 04)
Figure D (Tazarotene 05)
Figure E (Tazarotene 06)
Principal Display Panel (50 g Can Carton)
This is a description of a medication called Tazarotene Foam. It contains 1mg/g tazarotene, as well as other ingredients such as ascorbic acid and butylated hydroxytoluene. The medication is intended for topical use only and comes in a pressurized canister. The canister should be shaken before use and held upright while dispensing. The medication should be used only as prescribed by a physician and should be kept out of reach of children. The canister should not be punctured or exposed to heat, and should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The manufacturer is Mayne Pharma, and the product is distributed in Canada. There is contact information provided for suspected adverse reactions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
